A fluorogenic peptid substrate used for measuring chymotrypsin-like activity of the proteasome. Hydrolysis of this substrate by the β5 subunit of the 20S proteasome is monitored by observing fluorescence at an Excitation wavelength of 345nm and Emission at 445nm.
Ac-Trp-Leu-Ala-AMC is a synthetic fluorogenic peptide substrate widely utilized in biochemical research to study protease activity, particularly within the context of enzymology and protein function analysis. Structurally, it consists of an N-terminal acetylated tripeptide sequence—tryptophan, leucine, and alanine—linked to the fluorophore 7-amino-4-methylcoumarin (AMC) at the C-terminus. Upon enzymatic cleavage, AMC is released, producing a measurable fluorescent signal. This property makes the compound a valuable tool for real-time, quantitative assessment of proteolytic enzymes, enabling precise monitoring of enzyme kinetics and substrate specificity in a variety of experimental systems.
Enzyme Activity Assays: Ac-Trp-Leu-Ala-AMC is extensively employed in the development and optimization of in vitro enzyme activity assays, particularly for serine and cysteine proteases. The peptide-AMC conjugate serves as a sensitive reporter substrate; proteolytic cleavage liberates the AMC moiety, resulting in a quantifiable increase in fluorescence. This allows researchers to monitor enzyme kinetics in real time, facilitating detailed studies of catalytic efficiency, substrate turnover, and inhibitor screening under controlled laboratory conditions.
Substrate Specificity Profiling: The defined sequence of Ac-Trp-Leu-Ala-AMC enables its use in substrate specificity profiling for proteases. By comparing enzyme activity with this substrate against other peptide-AMC conjugates, investigators can elucidate the sequence preferences and cleavage site selectivity of target enzymes. Such studies are critical for characterizing novel proteases, refining substrate design, and understanding the molecular determinants of enzyme-substrate recognition.
High-Throughput Screening: The fluorogenic nature of the AMC label makes this peptide substrate highly suitable for high-throughput screening (HTS) applications. Automated platforms can rapidly assess large compound libraries for potential protease inhibitors or activators by measuring changes in fluorescence. This approach accelerates the discovery of modulators with desired biochemical properties, supporting drug discovery, functional genomics, and enzyme engineering projects.
Mechanistic Enzymology: Ac-Trp-Leu-Ala-AMC is often utilized in mechanistic studies of proteolytic enzymes to dissect catalytic pathways and intermediate formation. The ability to monitor substrate turnover with high temporal resolution enables detailed investigations into reaction mechanisms, including the effects of cofactors, allosteric modulators, or post-translational modifications on enzyme function. Such insights are valuable for advancing understanding of protease regulation and designing targeted biochemical interventions.
Protease Inhibitor Evaluation: The compound is frequently applied in the evaluation and characterization of protease inhibitors. By providing a robust, quantitative readout of enzyme activity, it facilitates the assessment of inhibitor potency, selectivity, and mode of action. Researchers can use the substrate in dose-response experiments, kinetic analyses, or competitive binding studies, generating critical data for the development of novel inhibitory compounds or the validation of screening hits in lead optimization workflows.
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More